| The epidemiology of obesity |
198 |
| Obesity and cancer risk: Emerging biological mechanisms and perspectives |
77 |
| Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics |
60 |
| Obesity and cardiovascular disease: revisiting an old relationship |
47 |
| Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis |
43 |
| Circadian regulation of glucose, lipid, and energy metabolism in humans |
35 |
| Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood |
33 |
| Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes |
32 |
| Metabolically healthy versus metabolically unhealthy obesity |
29 |
| Genetics and epigenetics in obesity |
28 |
| Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes |
27 |
| Pharmacotherapy of obesity: Available medications and drugs under investigation |
26 |
| Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-kappa B pathway |
25 |
| Obesity and dyslipidemia |
25 |
| The hypothalamus-pituitary-gonad axis: Tales of mice and men |
24 |
| Angiotensin-(1-7), Adipokines and Inflammation |
23 |
| Pharmacotherapy of type 2 diabetes: An update |
23 |
| Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study |
23 |
| Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences |
23 |
| Hypophosphatasia |
23 |
| Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy |
22 |
| Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease |
21 |
| The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men |
20 |
| Keto-adaptation enhances exercise performance and body composition responses to training in endurance athletes |
20 |
| Exercise-induced 'browning' of adipose tissues |
20 |
| Coordination of mitochondrial biogenesis by PGC-1 alpha in human skeletal muscle: A re-evaluation |
19 |
| Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study |
19 |
| FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity |
18 |
| IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice |
17 |
| Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease |
17 |
| Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism |
17 |
| Understanding vitamin D metabolism in pregnancy: From physiology to pathophysiology and clinical outcomes |
16 |
| Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis |
16 |
| Iron-induced oxidative stress stimulates osteoclast differentiation via NF-kappa B signaling pathway in mouse model |
16 |
| Overexpression of Sirt1 in mesenchymal stem cells protects against bone loss in mice by FOXO3a deacetylation and oxidative stress inhibition |
16 |
| The pathogenesis of obesity |
16 |
| Activation of ACE2/angiotensin (1-7) attenuates pancreatic beta cell dedifferentiation in a high-fat-diet mouse model |
15 |
| Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine |
15 |
| Exercise in the management of obesity |
15 |
| Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box! |
15 |
| Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome |
14 |
| Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men |
14 |
| Fibroblast growth factor 21 in non-alcoholic fatty liver disease |
14 |
| Developmental origins of adult health and disease: The metabolic role of BDNF from early life to adulthood |
14 |
| Osteogenesis imperfecta - A clinical update |
14 |
| Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPAR alpha signaling in ob/ob and db/db transgenic mouse models |
13 |
| Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors |
13 |
| White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging |
13 |
| Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study |
13 |
| Sleep devices: wearables and nearables, informational and interventional, consumer and clinical |
13 |
